🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
G&E Herbal Biotechnology Co., Ltd. (TPEX:4911)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
22.50
-2.50 (-10.00%)
Nov 20, 2026, 1:30 PM CST

G&E Herbal Biotechnology Balance Sheet

Millions TWD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
46.4678.41152.59139.68114.7512.28
Short-Term Investments
281.9351.9256.29173.2491.296.6
Cash & Short-Term Investments
328.36430.31408.87312.92205.95108.88
Cash Growth
-20.20%5.24%30.66%51.94%89.15%-9.31%
Accounts Receivable
20.0317.0617.814.780.755.09
Other Receivables
13.660.240.160.150.020.03
Receivables
33.6917.3117.9614.930.775.12
Inventory
23.8325.321.7122.924.6419.83
Prepaid Expenses
9.271.782.381.411.322.07
Total Current Assets
395.15474.69450.92352.17232.69135.9
Property, Plant & Equipment
364.08366.04372.31375.12375.15382.85
Other Intangible Assets
132.64132.73133.33133.89134.68135.51
Long-Term Deferred Tax Assets
7.90.350.2619.6537.9537.59
Other Long-Term Assets
1.271.422.372.272.310.28
Total Assets
901.04975.22959.17883.1782.78692.13

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
5.47.538.344.038.972.73
Accrued Expenses
2.5215.4817.7217.348.111.64
Current Portion of Leases
0.940.780.880.69--
Current Income Taxes Payable
-15.623.1---
Current Unearned Revenue
-0.1385.2395.2471.850.45
Other Current Liabilities
8.77.529.511.282.823.85
Total Current Liabilities
17.5647.05124.77118.5791.748.68
Long-Term Leases
1.580.090.871.29--
Long-Term Deferred Tax Liabilities
0.1---0.2-
Total Liabilities
19.2447.15125.64119.8691.948.68

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
688.17637.2590556.6556.6556.6
Additional Paid-In Capital
134.24134.24134.24134.24273.33273.33
Retained Earnings
59.39156.64109.372.4-139.09-146.47
Shareholders' Equity
881.8928.07833.53763.24690.84683.45
Total Liabilities & Equity
901.04975.22959.17883.1782.78692.13

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
2.520.871.751.98--
Net Cash (Debt)
325.83429.44407.13310.94205.95108.88
Net Cash Growth
-20.60%5.48%30.93%50.98%89.15%-9.31%
Net Cash Per Share
4.756.235.914.512.991.58
Filing Date Shares Outstanding
65.7468.8268.8268.8268.8268.82
Total Common Shares Outstanding
65.7468.8268.8268.8268.8268.82
Working Capital
377.59427.64326.14233.6140.95127.22
Book Value Per Share
13.4113.4912.1111.0910.049.93
Tangible Book Value
749.16795.34700.21629.34556.16547.95
Tangible Book Value Per Share
11.4011.5610.179.158.087.96
Land
-148.59148.59148.59148.59148.59
Buildings
-233.86233.58233.58233.08233.39
Machinery
-49.550.7752.0855.0655.32
Construction In Progress
-2.592.39---
Leasehold Improvements
-5.335.335.335.335.33